Page 22 - 南京医科大学学报自然科学版
P. 22

第42卷第7期
               ·918 ·                            南 京    医 科 大 学 学         报                        2022年7月


              A                  iDC                LPS⁃iDC                tolDC              LPS⁃tolDC
                       100 CFSE⁃      CFSE+  100  CFSE⁃    CFSE+  100  CFSE⁃     CFSE+  100  CFSE⁃    CFSE+
                          63.0%       37.0%    86.8%       13.2%     43.3%       56.7%    54.8%       45.2%
                       80                    80                   80                   80
                      2.5HIP组  60            60                   60                   60
                                             40
                       40
                                                                  40
                                                                                       40
                       20                    20                   20                   20
                        0                    0                     0                    0
                         10 0  10 1  10 2  10 3  10 4  10 0  10 1  10 2  10 3  10 4  10 0  10 1  10 2  10 3  10 4  10 0  10 1  10 2  10 3  10 4
                       100  CFSE⁃     CFSE+  100  CFSE⁃    CFSE+  100  CFSE⁃     CFSE+  100  CFSE⁃    CFSE+
                          4.32%       95.7%    3.81%        96.2%    1.68%       98.3%    4.32%       95.7%
                       80                    80                   80                   80
                      无关肽组  60               60                   60                   60

                                                                                       40
                                             40
                                                                  40
                       40
                       20                    20                   20                   20
                        0                    0                     0                    0
                         10 0  10 1  10 2  10 3  10 4  10 0  10 1  10 2  10 3  10 4  10 0  10 1  10 2  10 3  10 4  10 0  10 1  10 2  10 3  10 4
                             CFSE                          ***        □ 无关肽组
                                                 100           ***    ■ 2.5HIP组
                                                ( % )  80
                                                增殖比例  40
                                                  60
                                                  20
                                                   0
                                                      iDC LPS⁃iDC  tolDC LPS⁃tolDC

              B
                                iDC                  LPS⁃iDC               tolDC              LPS⁃tolDC
                        5 2.41%       83.1%  5 3.38%       86.6%  5                     5
                      10                    10                   10  1.57%      17.1%  10  4.57%     45.9%
                      10 4                  10 4                 10 4                 10 4
                     2.5HIP组  10 3 2        10 3 2               10 3 2      Q5       10 3 2

                      10
                                                                                      10
                                                                 10
                                            10
                                                                             4.61
                      10 1                  10 1                 10 1                 10 1
                         8.38%        6.12%    5.09%       4.96%    53.6%       27.8%    35.3%       14.2%
                          10 1   10 2  10 3    10 1   10 2  10 3    10 1   10 2  10 3     10 1  10 2   10 3
                        5 1.57%       6.22%  5  2.23%      6.91%  5 1.67%       2.75%  5  4.61%       4.41%
                      10                    10                   10                   10
                      10 4                  10 4                 10 4                 10 4
                     无关肽组  10 3 2           10 3 2               10 3 2               10 3 2
                      10
                                                                                      10
                                                                 10
                                            10
                      10 1                  10 1                 10 1                 10 1
                         67.2%        25.0%    78.8%       12.1%    81.6%       14.0%    76.5%       14.5%
                          10 1   10 2  10 3    10 1   10 2  10 3     10 1  10 2  10 3     10 1   10 2  10 3
                             CD44                100       ***        □ 无关肽组
                                                 ( % )  80     ***    ■ 2.5HIP组
                                                 CD44 + CD69 +  60
                                                  40
                                                  20
                                                   0
                                                      iDC LPS⁃iDC  tolDC
                                                               LPS⁃tolDC

                 A:BDC2.5 CD4 T细胞与各组2.5HIP⁃DC 按10∶1共培养后的增殖情况(图中灰色为CFSE 母峰对照组);B:活化情况(CD44 CD69 所占比
                                                                                                         +
                                                                                                     +
                            +
              例)。两组比较, P < 0.001,n:3~4。
                         ***
                                         +
                           图3 BDC2.5 CD4 T细胞与负载2.5HIP的DC共培养后的增殖活化情况及产生Treg的比例
                 Figure 3  Proliferation,activation and proportion of Treg of BDC2.5 CD4 T cells co⁃cultured with 2.5HIP⁃loaded DC
                                                                          +
   17   18   19   20   21   22   23   24   25   26   27